author-photo

Mengya Liu

Takeda Pharmaceutical Company

6

Papers

28

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Innovative trial designs and analyses for vaccine clinical development.

2021 Contemporary Clinical Trials
Show All
- Source
- Cite
- Save
Citations (4)
Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).

2021 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial.

2021 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (5)
Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults.

2020 Vaccine
Show All
- Source
- Cite
- Save
Citations (12)